Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Albert Faro, MD, vice president for clinical affairs at the Cystic Fibrosis Foundation (CFF). Dr. Faro speaks about COVID-19's impact on the CF community, and on how CFTR modulators and better care have dramatically extended the life of patients with cystic fibrosis.